With a focus on biotechnology and pharmaceuticals, Sintetica is at the forefront of developing cutting-edge medical treatments.
Although no specific details are available regarding their last investment or investors, the company's long-standing presence in the industry and dedication to innovation make it an attractive potential investment opportunity in the pharmaceutical sector. Based in Switzerland, Sintetica is poised to continue making significant strides in improving healthcare through its innovative approach to drug development.